Detection of Bladder Cancer Using Novel DNA Methylation Biomarkers in Urine Sediments
暂无分享,去创建一个
Yair Lotan | Shoudan Liang | Y. Lotan | B. Czerniak | J. Issa | J. Jelinek | W. Chung | J. Bondaruk | S. Liang | Jean-Pierre J Issa | Bogdan Czerniak | Woonbok Chung | Jolanta Bondaruk | Jaroslav Jelinek | S. Liang
[1] Gangning Liang,et al. Detection of Methylated Apoptosis-Associated Genes in Urine Sediments of Bladder Cancer Patients , 2004, Clinical Cancer Research.
[2] Bernhard Walter,et al. Clinically relevant reduction in risk of recurrence of superficial bladder cancer using 5-aminolevulinic acid-induced fluorescence diagnosis: 8-year results of prospective randomized study. , 2007, Urology.
[3] J Alfred Witjes,et al. Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials. , 2006, European urology.
[4] Peter A. Jones,et al. DNA methylation analysis by digital bisulfite genomic sequencing and digital MethyLight , 2008, Nucleic acids research.
[5] E A Sickles,et al. Screening mammography in community practice: positive predictive value of abnormal findings and yield of follow-up diagnostic procedures. , 1995, AJR. American journal of roentgenology.
[6] S. Belinsky,et al. Gene-promoter hypermethylation as a biomarker in lung cancer , 2004, Nature Reviews Cancer.
[7] Yair Lotan,et al. Quantitation of Aurora kinase A gene copy number in urine sediments and bladder cancer detection. , 2008, Journal of the National Cancer Institute.
[8] K. Kerlikowske,et al. Positive predictive value of screening mammography by age and family history of breast cancer. , 1993, JAMA.
[9] A. Gazdar,et al. Filling the void: urinary markers for bladder cancer risk and diagnosis. , 2001, Journal of the National Cancer Institute.
[10] M. Babjuk,et al. EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder. , 2008, European urology.
[11] D. Goodlett,et al. Stromal mesenchyme cell genes of the human prostate and bladder , 2005, BMC urology.
[12] K. Kerlikowske,et al. Positive predictive value of specific mammographic findings according to reader and patient variables. , 2009, Radiology.
[13] E. Messing,et al. Detection of bladder cancer using a point-of-care proteomic assay. , 2005, JAMA.
[14] Michael Ittmann,et al. Identification of Novel Tumor Markers in Prostate, Colon and Breast Cancer by Unbiased Methylation Profiling , 2008, PloS one.
[15] D. Chan,et al. Complexed prostate specific antigen provides significant enhancement of specificity compared with total prostate specific antigen for detecting prostate cancer. , 2000, The Journal of urology.
[16] L. Tanoue. Cancer Statistics, 2009 , 2010 .
[17] M. Knowles,et al. Structure and methylation-based silencing of a gene (DBCCR1) within a candidate bladder cancer tumor suppressor region at 9q32-q33. , 1998 .
[18] K. To,et al. Hypermethylation of multiple genes in tumor tissues and voided urine in urinary bladder cancer patients. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.
[19] K A Baggerly,et al. Sensitive and quantitative universal Pyrosequencing methylation analysis of CpG sites. , 2003, BioTechniques.
[20] Yi Guo,et al. Sensitive and specific detection of early gastric cancer with DNA methylation analysis of gastric washes. , 2009, Gastroenterology.
[21] M. Knowles,et al. Hypermethylation at 9q32-33 tumour suppressor region is age-related in normal urothelium and an early and frequent alteration in bladder cancer , 2001, Oncogene.
[22] E Gabrielson,et al. Aberrant methylation of p16(INK4a) is an early event in lung cancer and a potential biomarker for early diagnosis. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[23] R. Uzzo,et al. Detection of Bladder Cancer in Urine by a Tumor Suppressor Gene Hypermethylation Panel , 2004, Clinical Cancer Research.
[24] M. Swellam,et al. Noninvasive diagnosis of bladder cancer by detection of matrix metalloproteinases (MMP-2 and MMP-9) and their inhibitor (TIMP-2) in urine. , 2007, European urology.
[25] Richard M Hoffman,et al. Prostate-specific antigen testing accuracy in community practice , 2002, BMC family practice.
[26] Louis R Kavoussi,et al. Effect of patient age on early detection of prostate cancer with serum prostate-specific antigen and digital rectal examination. , 1993, Urology.
[27] François Radvanyi,et al. Frequent loss of heterozygosity on chromosome 10q in muscle-invasive transitional cell carcinomas of the bladder , 1997, Oncogene.
[28] Z. Estrov,et al. Genome-wide DNA methylation profiling of chronic lymphocytic leukemia allows identification of epigenetically repressed molecular pathways with clinical impact , 2010, Epigenetics.
[29] Li Zhang,et al. Genome-Wide Profiling of DNA Methylation Reveals a Class of Normally Methylated CpG Island Promoters , 2007, PLoS genetics.
[30] G. Papanicolaou,et al. URINE SEDIMENT SMEARS AS A DIAGNOSTIC PROCEDURE IN CANCERS OF THE URINARY TRACT. , 1945, Science.
[31] Pearlly S Yan,et al. High-throughput methylation profiling by MCA coupled to CpG island microarray. , 2007, Genome research.
[32] R. Hruban,et al. Identification and characterization of differentially methylated CpG islands in pancreatic carcinoma. , 2001, Cancer research.
[33] S. Goodman,et al. Quantitation of promoter methylation of multiple genes in urine DNA and bladder cancer detection. , 2006, Journal of the National Cancer Institute.
[34] M. Swellam,et al. Detection of telomerase in urine by 3 methods: evaluation of diagnostic accuracy for bladder cancer. , 2007, The Journal of urology.
[35] Edmund Chiong,et al. The use of short tandem repeat profiling to characterize human bladder cancer cell lines. , 2009, The Journal of urology.
[36] J. Califano,et al. Quantitative Detection of Promoter Hypermethylation of Multiple Genes in the Tumor, Urine, and Serum DNA of Patients with Renal Cancer , 2004, Cancer Research.
[37] Peter A. Jones,et al. The fundamental role of epigenetic events in cancer , 2002, Nature Reviews Genetics.
[38] Peter A. Jones,et al. Unique DNA methylation patterns distinguish noninvasive and invasive urothelial cancers and establish an epigenetic field defect in premalignant tissue. , 2010, Cancer research.
[39] Gary L Rosner,et al. Tumour vasculature: On the verge of collapse , 2005, Nature Reviews Cancer.
[40] E. Messing,et al. Bladder tumor markers beyond cytology: International Consensus Panel on bladder tumor markers. , 2005, Urology.
[41] B. Têtu,et al. The early clinical course of primary Ta and T1 bladder cancer: a proposed prognostic index. , 1998, British journal of urology.
[42] H Stepp,et al. Detection of early bladder cancer by 5-aminolevulinic acid induced porphyrin fluorescence. , 1996, The Journal of urology.
[43] W. Catalona,et al. Measurement of prostate-specific antigen in serum as a screening test for prostate cancer. , 1991, The New England journal of medicine.
[44] W. El-Rifai,et al. CpG island methylation in Schistosoma- and non-Schistosoma-associated bladder cancer , 2004, Modern Pathology.
[45] T. Ratliff. Urine markers for bladder cancer surveillance: a systematic review. , 2005, The Journal of urology.
[46] T. Hajdinjak. UroVysion FISH test for detecting urothelial cancers: meta-analysis of diagnostic accuracy and comparison with urinary cytology testing. , 2008, Urologic oncology.
[47] Tongyu Zhu,et al. A Novel Set of DNA Methylation Markers in Urine Sediments for Sensitive/Specific Detection of Bladder Cancer , 2007, Clinical Cancer Research.
[48] Elin Gustavsson,et al. SOX11 expression correlates to promoter methylation and regulates tumor growth in hematopoietic malignancies , 2010, Molecular Cancer.
[49] B. Roe,et al. A novel member of the WD-repeat gene family, WDR11, maps to the 10q26 region and is disrupted by a chromosome translocation in human glioblastoma cells , 2001, Oncogene.
[50] R. Sylvester,et al. Factors affecting recurrence and progression in superficial bladder tumours. , 1995, European journal of cancer.
[51] C. Roehrborn,et al. Sensitivity and specificity of commonly available bladder tumor markers versus cytology: results of a comprehensive literature review and meta-analyses. , 2003, Urology.
[52] M. J. Bailey,et al. Urinary markers in bladder cancer , 2003, BJU international.
[53] S. Baylin,et al. Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon , 1994, Nature Genetics.
[54] M. Swellam,et al. Expression of HYAL1 and survivin RNA as diagnostic molecular markers for bladder cancer. , 2010, The Journal of urology.
[55] L M Schuman,et al. The effect of fecal occult-blood screening on the incidence of colorectal cancer. , 2000, The New England journal of medicine.
[56] P Schneede,et al. Endoscopic detection of transitional cell carcinoma with 5-aminolevulinic acid: results of 1012 fluorescence endoscopies. , 2001, Urology.